Product/Composition:- | Etodolac tablets |
---|---|
Strength:- | 200 mg, 300 mg, 400 mg, 500 mg |
Form:- | Oral Tablets |
Reference Brands:- | Lodine(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Etodolac inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. Benefits include effective relief from arthritis pain, inflammation, and osteoarthritis, with a favorable safety profile. Its once or twice daily dosing offers convenient, targeted treatment for chronic pain conditions.
Etodolac tablets are approved in the EU and US for managing arthritis and inflammatory pain. In the EU, brands like Lodine are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, biosimilarity, and pharmacovigilance. Both regions require comprehensive dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for etodolac tablets, ensuring adherence to European and American standards for safe, effective anti-inflammatory therapy, helping you navigate complex regulatory pathways seamlessly.